Hem 2018-06-18T07:59:15+00:00

Treatment solutions and medical devices trusted by professionals worldwide

Our Scandinavian design brings you unparalleled ease of use and patient comfort.
Get a quote
Find your local Sooma distributor
We value good care and want to improve the tools available in routine healthcare.
Sooma Solutions
Sooma Depression Therapy

Sooma Depression Therapy provides a fast and effective depression relief.

It is a CE-, TGA- and HSA-approved solution for healthcare professionals.

Learn more
Sooma Pain Therapy

Sooma Pain Therapy provides a fast, effective and opioid-free analgesia.

It is a CE- and Health Canada-approved solution for healthcare professionals.

Learn more
Sooma Technology

Sooma tDCS

The easiest neurostimulator ever made
Sooma tDCS™ is an effective and easy-to-use solution for professionals, optimised for use in clinical routine.
The system features an intuitive workflow-based operation that is controlled with a single button. Automated safety features such as continuous contact monitoring provide the ultimate level of safety and patient comfort.
Sooma tDCS™ is the optimal tool for outcome studies. It supports double-blind condition and can be configured for multiple study protocols. Moreover, Sooma tDCS™ enables you to scale up your research with home-based, self-administered use.
Do exceptional tDCS with Sooma
Sooma tDCS device and a head cap
Medical grade quality
Healthcare professionals deserve only the highest quality of tools. This is why we have designed and tested Sooma tDCS as a class IIa medical device.
To ensure continuous quality, the system is designed using ISO 13485 and ISO 9001 and is manufactured in Finland.

Sooma Comfort

The best patient contact surface
Sooma Comfort is a family of stimulation accessories for transcranial electrical stimulation. The family consists of a head cap, stimulation electrodes and stimulation pads.
With Sooma Comfort, you are able to achieve better contact quality with faster preparation when compared to traditional rubber electrodes. The burden of a session is reduced as less time is needed in the preparation phase. Moreover, the benefits of being able to drastically improve the contact quality can really change the way we perform stimulation.
Offer stimulation with maximum patient comfort
World leader in home-based neuromodulation
Sooma tDCS combined with our remote patient management software represents state-of-the-art in home-based neuromodulation. Log in with your web browser and in 2 minutes, you know how all your home-based patients are doing.
Learn more about home-based therapy

Meet us at:

18th WPA World Congress of Psychiatry

September 27 - September 30

Book a meeting with us
Find your local Sooma distributor

Recent news and blog posts:

Sooma tDCS Self-administration & Home-use


Sooma tDCS Self-administration & Home-use Sooma Depression Therapy and Sooma Pain Therapy, conducted with the Sooma tDCS device, are so easy and convenient that the treatment can be self-administered by the patients themselves at [...]

What treatment outcomes tDCS gives for depression


What treatment outcomes tDCS gives for depression? During last few years, transcranial direct current stimulation (tDCS) has become an established treatment option for the major depressive disorder. The latest meta-analysis concluded tDCS to [...]

Sooma accepted into the Young Innovative Companies program of Business Finland


We are happy to announce that Sooma Oy has been accepted into the Young Innovative Companies (YIC) program of Business Finland (formerly known as TEKES or Finnish Funding Agency for Technology and Innovation). The [...]

Sooma depression treatment receives HSA approval in Singapore


Helsinki, Finland - December 12, 2017 Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA) approval for its leading therapeutic platform Sooma tDCS. This approval allows Sooma and its distributor Equip [...]

Trial of Escitalopram versus tDCS for Depression


Many of us who follow the science of electrical stimulation had high expectations when, in June, New England Journal of Medicine published the results of a big RCT by Brunoni et al. I know [...]